3The mechanism and the update therapeutic interventions for patients with obstructive sleep apnea and atrial fibrillationReview9-13
6Clinical significance of mean platelet volume in the diagnosis and treatment of cardiovascular diseaseReview22-26
7Evaluation of left ventricular systolic function in patients with severe aortic stenosis with ejection fraction by three-dimensional spot tracking techniqueClinical practice27-31
8Relationship between serum bilirubin and lipid index and coronary Gensini scoreClinical practice31-34
9Clinical study of CYP2C19 gene polymorphism combined with thrombelastography in antiplatelet therapy after coronary interventionClinical practice34-38
10Echocardiographic detection and clinical significance of echogenic intracardiac foci in fetusesClinical practice39-41
11Relationship between rest myocardial perfusion imaging and echocardiography/magnetic resonance imaging in measuring left ventricular diameterClinical practice42-46
12Study on the relationship between atrial arrhythmias and P wave dispersion(Pd) in 24 h dynamic electrocardiogramClinical practice46-48
13The effect of open heart valve surgery under cardiopulmonary bypass on myocardial inflammatory responseZHOU Tao, HE WeiClinical practice49-52
15Clinical management of extracorporeal membrane oxygenation in subacute pulmonary embolism combined heart failure after surgeryFANG Yi-tan, GU Tian-xiang, TANG RuiClinical practice57-59
17Efficacy and safety of Xuezhikang and Ezetimibe combination therapy in the patients with dyslipidemiaClinical medication60-63
18Effects of different doses of Atorvastatin combined with Two dibutyryl cyclic adenosine phosphate calcium glycosides on cardiac function and NT-proBNP in patients with coronary heart disease complicated with chronic heart failureClinical medication64-68
19Effects of Dunyeguanxinning on homocysteine, lipid and vascular endothelial function in patients with coronary heart diseaseClinical medication68-73,后插1
20Clinical research of Shexiang Tongxin Diwan in the therapy of patients with coronary heart disease after the PCIClinical medication73-75
